Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071955
Status:
COMPLETED
Last Update Posted:
2013-12-19
First Post:
2003-11-04
Brief Title:
Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkins Lymphoma
Sponsor:
Organization:
National Cancer Institute NCI